放射肿瘤学市场分析及预测(按规模、份额、增长、趋势)2031 年

  • Report Code : TIPRE00004195
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 170
Buy Now

预计到 2031 年,放射肿瘤学市场规模将从 2023 年的 89.2444 亿美元增至 236.2056 亿美元。预计 2023-2031 年市场复合年增长率为 13.0%。放射肿瘤学技术的进步可能会在未来几年为市场带来关键趋势。

放射肿瘤学市场分析

政府和私营实体正在投资医疗基础设施,包括放射治疗中心,以提高服务质量和可用性。因此,随着癌症患病率的不断上升,放射肿瘤学市场受到支持放射肿瘤学发展的举措的推动,这些举措旨在为患者带来更好、更有效的治疗结果。此外,放射肿瘤学市场的公司参与产品发布、产品审批、合作、并购,预计这些将在未来几年为市场创造充足的机会。

放射肿瘤学市场概况

放射肿瘤学是发展最快的癌症治疗方式之一。技术进步和大众意识的提高是推动放射肿瘤学市场增长的主要因素之一。北美主导着放射肿瘤学市场,预计亚太地区在预测期内的复合年增长率最高。亚太地区市场的增长归因于拥有充足增长机会的发展中经济体。癌症已迅速成为印度的公共卫生问题。2020 年,该国报告了约 139 万例癌症病例。该病也是 2020 年世界主要死亡原因之一,造成约 1000 万人死亡。为了更成功地抗击癌症,印度政府实施了多项举措,重点是投入资源建设足够的癌症护理基础设施,以及实施大规模的常见癌症预防、控制和筛查计划。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

放射肿瘤学市场:

Radiation Oncology Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

放射肿瘤学市场驱动因素和机遇

癌症患病率上升利好放射肿瘤学市场

癌症是全球常见的健康问题之一,对社会影响巨大。根据世界卫生组织 (WHO) 的数据,癌症是全球死亡的主要原因;2022 年,癌症导致 2000 万例新发癌症病例和 970 万人死亡。预计到 2050 年,新发癌症病例数将达到约 3500 万例。根据 WHO 2024 年报告,肺癌是全球最常见的癌症死亡原因,其次是结直肠癌、肝癌、乳腺癌和胃癌,分别占癌症相关死亡总数的 18.7%、9.3%、7.8%、6.9% 和 6.8%。十大癌症类型的发病率如下表所示:

 

2022 年全球统计概览

癌症

2022 年新增病例总数

2 480 675

胸部

2 296 840

结肠直肠

1 926 425

前列腺

1 467 854

968,784

866,136

甲状腺

821 214

宫颈

662301

膀胱

614 298

国家冰球联盟

553,389

来源:全球癌症观察站

癌症发病率的不断上升导致对有效治疗方案的需求巨大。放射治疗是不断发展的治疗方案之一,对癌症患者具有有效的治疗效果。介入方法利用高剂量的辐射(如 X 射线和伽马射线)来杀死癌细胞。放射治疗主要用于早期癌症患者,但可以在治疗的任何阶段使用。各种类型的外束放射治疗用于治疗不同类型的癌症。例如,近距离放射治疗用于治疗乳腺癌、宫颈癌、眼癌、前列腺癌和头颈癌。此外,全身放射治疗(也称为放射性碘治疗)用于治疗甲状腺癌。因此,癌症患病率的不断上升和肿瘤学放射治疗的发展促进了放射肿瘤学市场的增长。

为放射肿瘤学市场增长创造机会的战略举措

放射肿瘤学市场中的公司正在产品开发、创新、发布和批准、合并、收购和合作方面不断努力,为放射治疗的发展做出贡献。下面提到了近年来市场上发生的一些最新战略举措。

  • 2024 年 5 月,Elekta 推出了其最新的直线加速器 (linac),名为 Evo。这款具有全新高清 AI 增强成像的计算机断层扫描 (CT) 直线加速器能够提供离线和在线自适应放射治疗以及标准更高的图像引导放射治疗。
  • 2024年5月,Icon集团与Cyber​​knife Australia Pty Ltd合作建立最多6家新的放射肿瘤诊所(拟议的合资企业),目标是使用“Cyber​​knife”系统提供放射肿瘤治疗。
  • 2024 年 5 月,GE HealthCare 推出了 Revolution RT,这是一款具有创新硬件和软件产品的新型 CT 放射治疗解决方案,可帮助提高成像准确性,同时简化模拟工作流程,为临床医生和患者提供更加个性化、无缝的癌症护理流程。
  • 2024 年 4 月,Accuray Incorporated 在 ESTRO 2024 上展示了旨在改善癌症治疗体验的硬件和软件方面的进步。最新一代的 Cyber​​Knife 和 Radixact 平台为医疗团队提供了扩大放射治疗治愈能力所需的技术。
  • 2023 年 10 月,CIVCO Radiotherapy 与 Qfix 合作推出了新品牌 CQ Medical。该公司专注于改善癌症治疗和患者治疗效果,并与临床医生和技术合作伙伴在该领域展开深入合作。
  • 2023 年 9 月,MVision AI 推出了首个全面的基于指南的分割 (GBS) 解决方案,利用其 Guide、Verify 和 Contour+ 产品的功能实现有效的放射治疗轮廓勾画。Guide 有助于临床团队准确评估 AI 生成的结构,从而使他们能够提高勾画技能。Verify 系统允许对轮廓进行视觉和体积比较,帮助诊所观察相似点和差异点。Guide、Verify 和 Contour+ 的联合实施涵盖了放射治疗轮廓勾画的所有临床需求。

因此,放射肿瘤学市场参与者的战略举措预计将在未来几年为放射肿瘤学市场创造充足的机会

放射肿瘤学市场报告细分分析

有助于放射肿瘤学分析的关键部分是类型和应用。

  • 根据类型,放射肿瘤学市场分为外束放射治疗和内束放射治疗。外束放射治疗部分在 2023 年占据了更大的市场份额;然而,预计内束放射治疗在预测期内的复合年增长率会更高。
  • 根据应用,市场分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。乳腺癌领域在 2023 年占据了最大的市场份额;预计在 2023-2031 年期间将实现最高的复合年增长率。

放射肿瘤学市场份额按地区分析

放射肿瘤学报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。北美在放射肿瘤学市场中占据主导地位,这可以归因于该地区癌症患病率的上升以及技术的进步。预计美国将占据该地区市场的主导份额。该国拥有放射治疗专业知识的专业人员数量也在增加,这可以归因于发达的医疗保健基础设施的可及性。根据美国临床肿瘤学会的数据,全球约三分之二的癌症患者估计接受放射治疗作为治疗的一部分。2022 年,美国有超过 100 万癌症患者接受了放射治疗。政府和医疗机构正在采取多项举措鼓励采用放射治疗。2020 年 6 月,美国放射肿瘤学会 (ASTRO) 推出了关于非转移性宫颈癌放射治疗的新临床指南。新指南侧重于精确实施放射治疗的步骤和流程。预计亚太地区在 2023 年至 2031 年期间的复合年增长率最高。

 

放射肿瘤学市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响放射肿瘤学市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的放射肿瘤学市场细分和地理位置。

Radiation Oncology Market
  • 获取放射肿瘤学市场的区域特定数据

放射肿瘤学市场报告范围

报告属性细节
2023 年的市场规模89.2444亿美元
2031 年市场规模236.2056亿美元
全球复合年增长率(2023 - 2031)7.4%
史料2021-2022
预测期2024-2031
涵盖的领域按类型
  • 外照射放射治疗
  • 内照射放射治疗
按应用
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 头颈癌
  • 宫颈癌
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 瓦里安医疗系统公司
  • 医科达公司
  • 精确度公司
  • IBA Worldwide(离子束应用 SA)
  • 碧迪公司
  • Perspective Therapeutics公司
  • 诺迪恩
  • Mevion 医疗系统
  • NTP 放射性同位素
  • 马林克罗德股份有限公司

 

放射肿瘤学市场参与者密度:了解其对业务动态的影响

放射肿瘤学市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在放射肿瘤学市场运营的主要公司有:

  1. 瓦里安医疗系统公司
  2. 医科达公司
  3. 精确度公司
  4. IBA Worldwide(离子束应用 SA)
  5. 碧迪公司
  6. Perspective Therapeutics公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Radiation Oncology Market

 

  • 了解放射肿瘤学市场顶级关键参与者概况

放射肿瘤学市场新闻和最新发展

放射肿瘤学市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了市场的一些发展情况:

  • Curium 已为其镥-177 (Lu-177) DOTATATE 放射性药物提交了一份新药申请 (NDA),用于治疗生长抑素受体阳性胃肠胰神经内分泌肿瘤 (GEP-NETS)。该放射性药物旨在注射到患者体内,将 Lu-177 辐射直接输送到肿瘤。(Curium,公司网站,2024 年 7 月)
  • IBA 已与康涅狄格州质子治疗中心签订合同,该中心是耶鲁纽黑文健康中心、哈特福德医疗保健中心和 Proton International 的合作项目,将安装 Proteus ONE 紧凑型质子治疗系统。(IBA,公司网站,2024 年 5 月)
  • 瓦里安的 Halcyon 和 Ethos 放射治疗系统采用瓦里安的 HyperSight 成像解决方案,已获得美国食品药品监督管理局 (FDA) 的 510(k) 批准和欧盟的 CE 标志。HyperSight 使临床医生能够在日常放射治疗期间捕捉患者的高质量图像。(瓦里安,公司网站,2024 年 2 月)

放射肿瘤学市场报告覆盖范围和交付成果

“放射肿瘤学市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

  • 放射肿瘤学市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 放射肿瘤学市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 放射肿瘤学市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及放射肿瘤学市场的最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the radiation oncology market in 2023?

North America dominated the market in 2023.

What are the driving factors impacting the radiation oncology market?

The increasing prevalence of cancer and initiatives to support developments in radiation oncology are the pivotal factors fueling the market growth.

What would be the estimated value of the radiation oncology market by 2031?

The estimated value of the market would be US$ 23,620.56 million by 2031.

What are the future trends in the radiation oncology market?

Technological advancements are likely to bring attractive trends in the market in the coming years.

Which are the leading players operating in the radiation oncology market?

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc are among the key players in the market.

What is the expected CAGR of the radiation oncology market?

The market is expected to register a CAGR of 13% during 2023–2031.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Radiation Oncology Market

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuracy Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson & Co
  • Perspective Therapeutics Inc
  • Nordion
  • Mevion Medical Systems
  • NTP Radioisotopes
  •  Mallinckrodt Plc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.